Viewing Study NCT04997902

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-05-22 @ 5:35 PM
Study NCT ID: NCT04997902
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2021-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Sponsor: Kura Oncology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HNSCC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HRAS View
None PIK3CA View
None PI3K View
None Tipifarnib View
None Alpelisib View
None R/M HNSCC (Recurrent/metastatic Head and Neck Squamous Cell Carcinoma) View
None Head and Neck Cancer View
None SCCHN View